CAMK2N1 | |||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
Aliases | CAMK2N1, PRO1489, calcium/calmodulin dependent protein kinase II inhibitor 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
External IDs | OMIM: 614986 MGI: 1913509 HomoloGene: 10238 GeneCards: CAMK2N1 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Calcium/calmodulin dependent protein kinase II inhibitor 1 is a protein that in humans is encoded by the CAMK2N1 gene.[5]
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000162545 - Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000046447 - Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Entrez Gene: Calcium/calmodulin dependent protein kinase II inhibitor 1". Retrieved 2017-09-09.
Further reading
- Wang C, Li N, Liu X, Zheng Y, Cao X (2008). "A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization". J. Biol. Chem. 283 (17): 11565–74. doi:10.1074/jbc.M800436200. PMC 2431061. PMID 18305109.
- Wang T, Liu Z, Guo S, Wu L, Li M, Yang J, Chen R, Xu H, Cai S, Chen H, Li W, Wang L, Hu Z, Zhuang Q, Xu S, Wang L, Liu J, Ye Z, Ji JY, Wang C, Chen K (2014). "The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer". Oncotarget. 5 (11): 3611–21. doi:10.18632/oncotarget.1968. PMC 4116507. PMID 25003983.
- Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, Chen R, Liu X, Xu H, Cai S, Chen H, Li W, Xu S, Wang L, Hu Z, Zhuang Q, Wang L, Wu K, Liu J, Ye Z, Ji JY, Wang C, Chen K (2014). "CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling". Oncotarget. 5 (21): 10293–306. doi:10.18632/oncotarget.2511. PMC 4279373. PMID 25296973.
- Häfner N, Steinbach D, Jansen L, Diebolder H, Dürst M, Runnebaum IB (2016). "RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer". Int. J. Cancer. 138 (1): 217–28. doi:10.1002/ijc.29690. PMID 26175272.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.